Klerksdorp Midweek, Klerksdorp - The deteriorating condition of Lautz Avenue in La Hoff is hazardous, causes damage to vehicles and puts the lives of road users at serious risk.
“The residents of Ward 16 have repeatedly reported the potholes to the Municipality and even to the Director.
Klerksdorp Midweek, Potchefstroom - An orthopaedic surgeon, based at Lenmed MooiMed Private Hospital, performed a ground-breaking knee replacement surgery last week.
Dr Hannes Jonker - a member of the Orthosport group practice - performed the first Kinematically Aligned (KA) knee arthroplasty on the continent on Wednesday July 24, using the revolutionary SpheriKA prosthesis. Pioneering its regional debut, he completed not one but three successful KA procedures.
Klerksdorp Midweek, Potchefstroom - Die Noordwes-Universiteitsraad het die oud-Klerksdorper Jannie Oosthuizen vereer met ‘n eredoktorsgraad.
Die graad is op Vrydag 2 Augustus aan hom oorhandig. Oosthuizen is vereer vir uitstaande akademiese meriete in Aptekerswese en sy leierskap van Merck, ‘n Amerikaanse maatskappy betrokke by die vervaardiging van medisyne en entstowwe wat wêreldwyd sake doen. Die NWU wou hom ook vereer vir die uitsonderlike bydrae tot die bevordering van die NWU se visie en missie met sy roemryke internasionale loopbaan.
Triest Opleidingsentrum het die afgelope naweek ‘n fondsinsameling met ‘n verskil aangebied deur perde-resies met pret te kombineer. Dit was egter pret met ‘n hoofletter P wat aan die gaste opgedis is behalwe ook vir heerlike versnaperings en ‘n driegang-maatltyd. Gaste het opgetof vir die geleentheid en kon deelneem aan ‘n gymkana, stadige resies en dressering met kliënte van Triest wat te ‘perd’ met die rol van ‘n dobbelsteen ‘n afstand moes aflê. Die ‘perde’ is aan die einde van die aand opgeveil. Salomé Kotzé het ‘n paar foto’s geneem.
Klerksdorp Midweek, Potchefstroom - With the help of a particular enzyme, HIV/Aids cannot replicate itself and take over the body’s cells. Dr Andrew Motsilanyane, a recent PhD graduate from the North-West University (NWU), has been targeting this enzyme, HIV-1 protease, in research that could open up new possibilities for drug development. His work focuses on the critical role of HIV-1 protease in the virus’s lifecycle and emphasises the importance of targeting this enzyme in the development of integrase inhibitors. Integrase inhibitors are one of several classes of antiretroviral drugs used to treat HIV as part of antiretroviral therapy.
